{"created":"2023-05-15T14:52:48.386374+00:00","id":72097,"links":{},"metadata":{"_buckets":{"deposit":"b93bcd46-1e4d-4c21-b584-77ccb8022408"},"_deposit":{"created_by":1,"id":"72097","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"72097"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00072097","sets":["10:28"]},"author_link":["709957","709958","709954","709961","709962","709960","709959","709964","709965","709955","709963","709956"],"item_10005_date_7":{"attribute_name":"発表年月日","attribute_value_mlt":[{"subitem_date_issued_datetime":"2016-11-04","subitem_date_issued_type":"Issued"}]},"item_10005_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"[18F]2-fluoro-2-deoxyglucose ([18F]FDG) 注射液は合成装置のバリデーションとして比放射能及びClDG濃度を定期的に測定する必要があり、放医研では分析の受託を行っている。現在受託分析に使用している電気化学検出器クーロケムⅢの販売および点検サービスの終了に伴い、代替機として種々のメーカーの電気化学検出器を検討した結果、新たにECD-3000RSを導入し、[18F]FDG注射液の分析法を再検討した。その結果FDG及びClDGの濃度測定において、ともに0.01 ppmまでの低濃度での精密な分析を可能にした。さらに分析法バリデーションを行うことで、測定結果について一定の真度、精度を保証し、高い信頼性を示すことができた。実際の[18F]FDG注射液測定においても、受託している全ての合成装置による[18F]FDG注射液の分析に適用可能であり、FDGは0.068-0.54 ppm, ClDGは0.068-22 ppmであった。以上より、新規検出器及び分析法は受託分析に適していることを示した。","subitem_description_type":"Abstract"}]},"item_10005_description_6":{"attribute_name":"会議概要（会議名, 開催地, 会期, 主催者等）","attribute_value_mlt":[{"subitem_description":"第56回日本核医学会学術総会にポスター発表の為","subitem_description_type":"Other"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"橋本, 裕輝"}],"nameIdentifiers":[{"nameIdentifier":"709954","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"狩谷, 香"}],"nameIdentifiers":[{"nameIdentifier":"709955","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"古塚, 賢士"}],"nameIdentifiers":[{"nameIdentifier":"709956","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"河村, 和紀"}],"nameIdentifiers":[{"nameIdentifier":"709957","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"脇, 厚生"}],"nameIdentifiers":[{"nameIdentifier":"709958","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"張, 明栄"}],"nameIdentifiers":[{"nameIdentifier":"709959","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"橋本 裕輝","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"709960","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"狩谷 香","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"709961","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"古塚 賢士","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"709962","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"河村 和紀","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"709963","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"脇 厚生","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"709964","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"張 明栄","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"709965","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"conference object","resourceuri":"http://purl.org/coar/resource_type/c_c94f"}]},"item_title":"新規電気化学検出器による[18F]FDG注射液の受託分析","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"新規電気化学検出器による[18F]FDG注射液の受託分析"}]},"item_type_id":"10005","owner":"1","path":["28"],"pubdate":{"attribute_name":"公開日","attribute_value":"2016-12-21"},"publish_date":"2016-12-21","publish_status":"0","recid":"72097","relation_version_is_last":true,"title":["新規電気化学検出器による[18F]FDG注射液の受託分析"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T19:43:51.285595+00:00"}